HBV Therapies (Industry News)
RPI Announces Hepatitis B Virus Ribozyme Patent Issuance
Published in Hepatitis Weekly, February 7th, 2000
"The ribozyme approach to inhibiting viral replication was recently applied by RPI to the hepatitis C virus (HCV)," said Ralph E. Christoffersen, RPI. "We are pleased that this patent allows us to develop and commercialize products against HBV, and apply the insights from HCV to the process."
"The application of ribozymes to the treatment of hepatitis B represents a novel and potentially effective approach to this disease," said Myron J. Tong, PhD, MD, chief of the Liver Center, Huntington Memorial...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2000-02-07)
More Articles from Hepatitis Weekly
- HCV Vaccines
Six Mutant HCV Clone Derivatives Identified - Antiviral Response
IFN-gamma and iNOS Gene Expression Increased in HCV - Cirrhosis
HCV Lesions Not Affected by Liver Iron - Epidemiology (HBV)
Differences in HBV Genotypes Examined in South Africa - Liver Cancer
Stopping HCV is Best Way to Reduce Liver Cancers - Therapy (HCV)
IFN Cost Effective for Chronic HCV in Children - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
